Liver resection versus microwave ablation for hepatocellular carcinoma in ideal candidates for ablation per Barcelona Clinic Liver Cancer staging: a propensity score matching and inverse probability of treatment weighting analysis-Reference-Cited by-同舟云学术

Liver resection versus microwave ablation for hepatocellular carcinoma in ideal candidates for ablation per Barcelona Clinic Liver Cancer staging: a propensity score matching and inverse probability of treatment weighting analysis

Published:2022-10-26 Issue:11-12 Volume:56 Page:1602-1614
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Tong Yao¹,Cai Ran¹,Li Jun‐Xiang²,Chang De‐Hua³,Wang Li‐Zhou⁴,Cai Wen‐Wu⁵,Xiao Yu‐Dong¹^ORCID

Affiliation:

1. Department of Radiology The Second Xiangya Hospital of Central South University Changsha China

2. Department of Interventional Radiology Guizhou Medical University Affiliated Cancer Hospital Guiyang China

3. Department of Diagnostic and Interventional Radiology University Hospital Heidelberg Heidelberg Germany

4. Department of Interventional Radiology Affiliated Hospital of Guizhou Medical University Guiyang China

5. Department of Liver Surgery The Second Xiangya Hospital of Central South University Changsha China

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.17263

Reference27 articles.

1. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

2. AASLD guidelines for the treatment of hepatocellular carcinoma

3. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update

4. Development of Hong Kong Liver Cancer Staging System With Treatment Stratification for Patients With Hepatocellular Carcinoma

5. Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of proliferative hepatocellular carcinoma using the SMARS score and implications for microwave ablation;Insights into Imaging;2024-09-10

2. Survival Benefit of Lenvatinib Plus PD-1 Inhibitor with or Without HAIC in Advanced Hepatocellular Carcinoma Beyond Oligometastasis: a Multicenter Cohort Study;ImmunoTargets and Therapy;2024-09

3. Liver resection versus microwave ablation for solitary and small (≤ 3 cm) HCC with early recurrence in different stages of liver cirrhosis: A propensity score matching study;Asian Journal of Surgery;2024-07

4. Evaluation of the effectiveness of surgical resection and ablation for the treatment of early‐stage hepatocellular carcinoma: A retrospective cohort study;Cancer Reports;2024-03

5. The tumor burden score may be a discriminator in microwave ablation versus liver resection for hepatocellular carcinoma within the Milan criteria: a propensity score matching and inverse probability of treatment weighting study;Frontiers in Oncology;2024-02-16